This measure summary has been replaced by an updated version. Please update your bookmarks.
View the updated summary: Atrial fibrillation (AF) and atrial flutter: percentage of patients aged 18 years and older with a diagnosis of nonvalvular AF or atrial flutter whose assessment of the specified thromboembolism risk factors indicate one or more high-risk factors or more than one moderate risk factor, as determined by CHADS<sub>2 </sub>risk stratification, who are prescribed warfarin OR another oral anticoagulant drug that is FDA approved for the prevention of thromboembolism. NQMC:008971
View all updated summaries in the Measure Archive.
About NQMC Measure Summaries
New on NQMC
Myelodysplastic syndromes (MDS): percentage of MDS patients presenting with anemia who had a serum erythropoietin level less than or equal to 500 mU/ml prior to receiving erythropoietin/darbepoetin therapy.
New This Week
View more and sign up for our Newsletter